CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of Stat3 activation

Yu Ching Lin, Ming Szu Hung, Chin Kuo Lin, Jhy Ming Li, Kuan Der Lee, Ya Chin Li, Miao Fen Chen, Jan Kan Chen, Cheng Ta Yang

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

CK2 interacts and phosphorylates >300 proteins, including Stat3, and is linked to a number of human cancers. Constitutively activated Stat3 has been reported in 50% of human lung cancers. Inhibition of CK2 activity can induce apoptosis and suppression of Stat3 activation in cancer cells. This study examined the effects of CK2 inhibitors on growth inhibition of lung cancer cells and the therapeutic potential on lung cancer. The CK2 inhibitor and radiation both suppressed cancer cell growth in a dose-dependent manner. Besides, the cytotoxic effect of irradiation could be augmented by CK2 inhibitors (p<0.05, two-way analysis of variance and Tukey's Honestly Significant Difference). Moreover, the growth inhibition of CK2 inhibitor and irradiation was both associated with suppression of Stat3 activation. Taken together, inhibition of CK2 activity appears to be a promising treatment strategy for non-small cell lung cancer and CK2 inhibition results in reduced Stat3 activation. Our data warrant further effort to develop CK2-targeted radiosensitizer for lung cancer treatment.

Original languageEnglish
Pages (from-to)381-388
Number of pages8
JournalCancer Biotherapy and Radiopharmaceuticals
Volume26
Issue number3
DOIs
Publication statusPublished - Jun 1 2011
Externally publishedYes

Fingerprint

Radiation Tolerance
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Neoplasms
Growth Inhibitors
Growth
Analysis of Variance
Radiation
Apoptosis
Proteins
Therapeutics

Keywords

  • CK2
  • Irradiation
  • non-small cell lung cancer
  • Stat3

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology
  • Cancer Research

Cite this

CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of Stat3 activation. / Lin, Yu Ching; Hung, Ming Szu; Lin, Chin Kuo; Li, Jhy Ming; Lee, Kuan Der; Li, Ya Chin; Chen, Miao Fen; Chen, Jan Kan; Yang, Cheng Ta.

In: Cancer Biotherapy and Radiopharmaceuticals, Vol. 26, No. 3, 01.06.2011, p. 381-388.

Research output: Contribution to journalArticle

Lin, Yu Ching ; Hung, Ming Szu ; Lin, Chin Kuo ; Li, Jhy Ming ; Lee, Kuan Der ; Li, Ya Chin ; Chen, Miao Fen ; Chen, Jan Kan ; Yang, Cheng Ta. / CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of Stat3 activation. In: Cancer Biotherapy and Radiopharmaceuticals. 2011 ; Vol. 26, No. 3. pp. 381-388.
@article{bdb0d59a362248a09a9fd21329d5ff8d,
title = "CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of Stat3 activation",
abstract = "CK2 interacts and phosphorylates >300 proteins, including Stat3, and is linked to a number of human cancers. Constitutively activated Stat3 has been reported in 50{\%} of human lung cancers. Inhibition of CK2 activity can induce apoptosis and suppression of Stat3 activation in cancer cells. This study examined the effects of CK2 inhibitors on growth inhibition of lung cancer cells and the therapeutic potential on lung cancer. The CK2 inhibitor and radiation both suppressed cancer cell growth in a dose-dependent manner. Besides, the cytotoxic effect of irradiation could be augmented by CK2 inhibitors (p<0.05, two-way analysis of variance and Tukey's Honestly Significant Difference). Moreover, the growth inhibition of CK2 inhibitor and irradiation was both associated with suppression of Stat3 activation. Taken together, inhibition of CK2 activity appears to be a promising treatment strategy for non-small cell lung cancer and CK2 inhibition results in reduced Stat3 activation. Our data warrant further effort to develop CK2-targeted radiosensitizer for lung cancer treatment.",
keywords = "CK2, Irradiation, non-small cell lung cancer, Stat3",
author = "Lin, {Yu Ching} and Hung, {Ming Szu} and Lin, {Chin Kuo} and Li, {Jhy Ming} and Lee, {Kuan Der} and Li, {Ya Chin} and Chen, {Miao Fen} and Chen, {Jan Kan} and Yang, {Cheng Ta}",
year = "2011",
month = "6",
day = "1",
doi = "10.1089/cbr.2010.0917",
language = "English",
volume = "26",
pages = "381--388",
journal = "Cancer Biotherapy and Radiopharmaceuticals",
issn = "1084-9785",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of Stat3 activation

AU - Lin, Yu Ching

AU - Hung, Ming Szu

AU - Lin, Chin Kuo

AU - Li, Jhy Ming

AU - Lee, Kuan Der

AU - Li, Ya Chin

AU - Chen, Miao Fen

AU - Chen, Jan Kan

AU - Yang, Cheng Ta

PY - 2011/6/1

Y1 - 2011/6/1

N2 - CK2 interacts and phosphorylates >300 proteins, including Stat3, and is linked to a number of human cancers. Constitutively activated Stat3 has been reported in 50% of human lung cancers. Inhibition of CK2 activity can induce apoptosis and suppression of Stat3 activation in cancer cells. This study examined the effects of CK2 inhibitors on growth inhibition of lung cancer cells and the therapeutic potential on lung cancer. The CK2 inhibitor and radiation both suppressed cancer cell growth in a dose-dependent manner. Besides, the cytotoxic effect of irradiation could be augmented by CK2 inhibitors (p<0.05, two-way analysis of variance and Tukey's Honestly Significant Difference). Moreover, the growth inhibition of CK2 inhibitor and irradiation was both associated with suppression of Stat3 activation. Taken together, inhibition of CK2 activity appears to be a promising treatment strategy for non-small cell lung cancer and CK2 inhibition results in reduced Stat3 activation. Our data warrant further effort to develop CK2-targeted radiosensitizer for lung cancer treatment.

AB - CK2 interacts and phosphorylates >300 proteins, including Stat3, and is linked to a number of human cancers. Constitutively activated Stat3 has been reported in 50% of human lung cancers. Inhibition of CK2 activity can induce apoptosis and suppression of Stat3 activation in cancer cells. This study examined the effects of CK2 inhibitors on growth inhibition of lung cancer cells and the therapeutic potential on lung cancer. The CK2 inhibitor and radiation both suppressed cancer cell growth in a dose-dependent manner. Besides, the cytotoxic effect of irradiation could be augmented by CK2 inhibitors (p<0.05, two-way analysis of variance and Tukey's Honestly Significant Difference). Moreover, the growth inhibition of CK2 inhibitor and irradiation was both associated with suppression of Stat3 activation. Taken together, inhibition of CK2 activity appears to be a promising treatment strategy for non-small cell lung cancer and CK2 inhibition results in reduced Stat3 activation. Our data warrant further effort to develop CK2-targeted radiosensitizer for lung cancer treatment.

KW - CK2

KW - Irradiation

KW - non-small cell lung cancer

KW - Stat3

UR - http://www.scopus.com/inward/record.url?scp=79960051228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960051228&partnerID=8YFLogxK

U2 - 10.1089/cbr.2010.0917

DO - 10.1089/cbr.2010.0917

M3 - Article

VL - 26

SP - 381

EP - 388

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

SN - 1084-9785

IS - 3

ER -